Related references
Note: Only part of the references are listed.Effects of Chemotherapy in AIDS-Associated Non-Hodgkin's Lymphoma on Kaposi's Sarcoma Herpesvirus DNA in Blood
Lan Lin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Impact of HIV Infection and Kaposi Sarcoma on Human Herpesvirus-8 Mucosal Replication and Dissemination in Uganda
Christine Johnston et al.
PLOS ONE (2009)
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease
Anne-Genevieve Marcelin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients
Saverio G. Parisi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Intracellular tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: Role of JAK/STAT signaling
Yi Zeng et al.
JOURNAL OF VIROLOGY (2007)
Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma
Elizabeth E. Brown et al.
CANCER (2006)
Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy
V Martinez et al.
BRITISH JOURNAL OF CANCER (2006)
Persistence of Kaposi sarcoma associated herpesvirus (KSHV) infected cells in KSHV/HIV-1 coinfected subjects without KSHV-associated diseases
TB Campbell et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level
JP Viard et al.
AIDS (2004)
Repeated measures study of human herpesvirus 8 (HHV-8) DNA and antibodies in men seropositive for both HHV-8 and HIV
AS Laney et al.
AIDS (2004)
Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women
MM Taylor et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma
AG Marcelin et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma
EA Engels et al.
AIDS (2003)
Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus
MJ Cannon et al.
AIDS (2003)
Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma
J Gill et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)
Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta
V Varthakavi et al.
VIROLOGY (2002)
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy
SG Parisi et al.
AIDS (2002)
Update on Kaposils sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy
UR Hengge et al.
LANCET INFECTIOUS DISEASES (2002)
Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients
C Dupont et al.
AIDS (2000)
Human herpesvirus 8 infections in the Amsterdam Cohort Studies (1984-1997): Analysis of seroconversions to ORF65 and ORF73
J Goudsmit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon
G Rezza et al.
SEXUALLY TRANSMITTED DISEASES (2000)
Share Paper
